Dallas and Highland Park, Texas
Exosome supply and 503A pharmacy access for Dallas practices
ExaVeyra supplies research-use exosome material to licensed practices in Dallas County from its base in Miami Beach, and because Texas is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice in Dallas, Highland Park or University Park can source, how material arrives, and where the Texas law questions are answered.
It speaks to the practice rather than to a patient, names no condition or use, and defers the delegation and statute detail to the Texas sourcing guide.
What a Dallas and Highland Park practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Texas, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Dallas and Highland Park
Dallas is one of the largest aesthetic and longevity markets in the country, and the Texas sourcing guide records it as a dense med spa corridor with a large concierge segment. The clinical anchors are UT Southwestern Medical Center and the Southwestern Medical District west of downtown, and Baylor University Medical Center east of it, and a large share of the dermatology, plastic surgery and hormone-optimization practices in the market sit in the arc that runs from Uptown and Turtle Creek through the Park Cities to Preston Hollow and the North Dallas tollway corridor.
Highland Park and University Park, the two Park Cities enclosed by Dallas, have a concentrated concierge and private-practice population along Preston Road and the Knox and Henderson district, and the northern suburbs in Collin County, Plano and Frisco in particular, carry the market's fastest growth in newly opened aesthetic and functional medicine practices. Dallas Fort Worth International Airport is a major carrier gateway, which is why a Dallas address tends to sit at the short end of the Texas transit range.
Group practices are common here, and the account structure reflects that: a single verified practice can list several delivery addresses across Dallas, Collin and Tarrant counties, with every lot traceable to the site that received it and one set of documentation for the group. Medical office buildings on the Medical District and along the tollway generally run a staffed receiving desk during business hours, which makes a weekday delivery straightforward, and the receiving log is what the practice keeps.
The market's calendar is less seasonal than Florida's or Arizona's, though the summer heat sets the same receiving discipline: a package should not wait on a loading dock through a July afternoon. Practices in Preston Hollow, Lakewood and the Bishop Arts district in Oak Cliff tend to be solo or two-physician groups working from converted houses or small commercial buildings without a receiving desk, and for those the account names the staff member who signs and the hours they keep, so that the carrier's first attempt is the only one needed.
The hair and scalp literature, for Dallas and Highland Park practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Dallas practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription.
The Texas guide makes the point that applies most in a market with this many nurse-practitioner-led and physician-assistant-led practices: who may prescribe a compounded preparation, and under what delegation, is answered by the Texas Medical Board and the Texas Board of Nursing rather than by a supplier. A practice that reads the delegation table there before the first order avoids a common hold at the pharmacy, a prescription written under an arrangement the boards do not recognise.
How material reaches Dallas and Highland Park
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Texas practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Texas law is a separate question, answered in the state guide
What a Texas practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Texas sourcing guide rather than repeated here. Nothing about the city changes any of it.
Dallas and Highland Park sourcing questions
- How does material reach a Dallas practice from Miami Beach?
- Shipments dispatch from the Miami Beach facility under validated temperature monitoring and route through the carrier air network into the Dallas Fort Worth hub, then to the practice address on file. The Texas sourcing guide states the transit range for the state, and a Dallas County address sits at the short end of it because of the hub. Dispatch is scheduled so that a shipment does not sit over a weekend at a carrier facility, and the receiving checks described on the cold-chain page apply on arrival.
- Can a Dallas practice source both exosome material and compounded preparations?
- Yes. Texas is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber here can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to any licensed practice. The two are handled under separate regimes: the compounded preparation is dispensed by the pharmacy with its label and a beyond-use date, and the exosome material ships to the practice with a lot number and a certificate of analysis available on request.
- Does a practice in Plano or Frisco use the same lane as one in Highland Park?
- Yes. Collin County and Dallas County addresses are served through the same hub, hold the same compounding availability, and use the same account structure. A group with locations in both can list each delivery address on one account so that every lot is traceable to the site that received it.
Sources
- Texas Medical Board (accessed 15 September 2026)
- Texas State Board of Pharmacy (accessed 15 September 2026)
- Texas Board of Nursing (accessed 15 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.